SNNAQ (Sienna Biopharmaceuticals) EPS (Basic): $-2.00 (TTM As of Sep. 2019)


What is Sienna Biopharmaceuticals EPS (Basic)?

Sienna Biopharmaceuticals SNNAQ -99.00% EPS (Basic) is $-2.00 as of Sep. 2019.

Sienna Biopharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Sep. 2019 was $-0.13. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2019 was $-2.00.

Sienna Biopharmaceuticals's EPS (Diluted) for the three months ended in Sep. 2019 was $-0.13. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-2.00.

Sienna Biopharmaceuticals's EPS without NRI for the three months ended in Sep. 2019 was $-0.15. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2019 was -2.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Sienna Biopharmaceuticals  (OTCPK:SNNAQ) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sienna Biopharmaceuticals EPS (Basic) Related Terms

Sienna Biopharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals EPS (Basic) Chart

Sienna Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18
EPS (Basic)
-0.99 -1.86 -5.19 -3.59

Sienna Biopharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.82 -0.93 -0.67 -0.27 -0.13

Sienna Biopharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sienna Biopharmaceuticals's Basic EPS for the fiscal year that ended in Dec. 2018 is calculated as

Basic EPS (A: Dec. 2018 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-73.471-0)/20.450
=-3.59

Sienna Biopharmaceuticals's Basic EPS for the quarter that ended in Sep. 2019 is calculated as

Basic EPS (Q: Sep. 2019 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.97-0)/30.726
=-0.13

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-2.00 mean?
Sienna Biopharmaceuticals (SNNAQ) has a EPS (Basic) of $-2.00 as of Sep. 2019. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sienna Biopharmaceuticals and its competitors.
Is Sienna Biopharmaceuticals' EPS (Basic) too high?
Sienna Biopharmaceuticals' current EPS (Basic) is $-2.00.
How does Sienna Biopharmaceuticals' EPS (Basic) compare to GTHR and PPCB?
Sienna Biopharmaceuticals' EPS (Basic) of $-2.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sienna Biopharmaceuticals and its competitors. Sienna Biopharmaceuticals's current EPS (Basic) is $-2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current EPS (Basic) of $-2.00. The current EPS (Basic) is $-2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current EPS (Basic) is $-2.00 as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.